CBDA (cannabidiolic acid)

CBDA, short for cannabidiolic acid, is the abundant but inactive raw precursor to the renowned compound CBD found in living, unheated cannabis plants. Through decarboxylation, CBDA readily converts into activated CBD when exposed to heat, UV light, or other triggers. While CBD has taken center stage, research into the distinct benefits and therapeutic potential of CBDA is expanding rapidly as scientific interest grows around lesser known cannabis compounds beyond just CBD and THC. Promising studies already indicate CBDA effectively reduces acute nausea and vomiting more potently than CBD without intoxicating side effects. CBDA also demonstrates considerable anti-inflammatory properties similar to CBD. And the uncommon cannabinoid shows early promise for treating anxiety, depression, epilepsy, and obsessive-compulsive disorders based on limited trials and preclinical models. Maintaining higher CBDA levels alongside CBD may provide an amplified entourage effect and better equip the body to combat inflammation-related conditions. However, more double blind clinical human trails are still needed to fully elucidate CBDA’s mechanisms and applications.